268 related articles for article (PubMed ID: 21433057)
1. Design, synthesis and evaluation of novel rhodanine-containing sorafenib analogs as potential antitumor agents.
Li W; Zhai X; Zhong Z; Li G; Pu Y; Gong P
Arch Pharm (Weinheim); 2011 Jun; 344(6):349-57. PubMed ID: 21433057
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents.
Yao J; Chen J; He Z; Sun W; Xu W
Bioorg Med Chem; 2012 May; 20(9):2923-9. PubMed ID: 22483592
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 2-iminothiazolidin-4-one moiety-containing compounds as potent antiproliferative agents.
Zhai X; Li W; Chen D; Lai R; Liu J; Gong P
Arch Pharm (Weinheim); 2012 May; 345(5):360-7. PubMed ID: 22223396
[TBL] [Abstract][Full Text] [Related]
4. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors.
Zhan W; Li Y; Huang W; Zhao Y; Yao Z; Yu S; Yuan S; Jiang F; Yao S; Li S
Bioorg Med Chem; 2012 Jul; 20(14):4323-9. PubMed ID: 22721924
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity studies of novel 2-Hydrazonylpyrido[2,3-b]pyrazin-3(4H)-ones.
Zhang G; Liu Y; Wang S; Zhou C; Huang Q; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):49-56. PubMed ID: 21953529
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 4-(2-fluorophenoxy)-2-(1H-tetrazol-1-yl)pyridines bearing semicarbazone moieties as potent antitumor agents.
Qin M; Liao W; Xu C; Fu B; Ren J; Gu Y; Gong P
Arch Pharm (Weinheim); 2013 Nov; 346(11):840-50. PubMed ID: 24114959
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.
Karki R; Thapa P; Kang MJ; Jeong TC; Nam JM; Kim HL; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 May; 18(9):3066-77. PubMed ID: 20392646
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor evaluation of methyl spongoate analogs.
Jiang CS; Huang CG; Feng B; Li J; Gong JX; Kurtán T; Guo YW
Steroids; 2010 Dec; 75(13-14):1153-63. PubMed ID: 20728460
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.
Sun M; Wu X; Chen J; Cai J; Cao M; Ji M
Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
17. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of some N-sulphonated-2-substituted benzimidazoles and imidazo[4,5-b]pyridines.
Garuti L; Varoli L; Cermelli C; Baggio G; Lupo L; Malagoli M; Castelli M
Anticancer Drug Des; 1998 Dec; 13(8):969-80. PubMed ID: 10335270
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
